Education
About Us
Working with TipRanks
Follow Us
Linike Medical Group Ltd. (LNMG)
:LNMG
Total Valuation
Linike Medical Group has a market cap or net worth of $3.11M. The enterprise value is ―.
Market Cap$3.11M
Enterprise Value―
Share Statistics
Linike Medical Group has 509,474,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding509,474,370
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Linike Medical Group’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 1.90%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)1.90%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.16
Inventory Turnover0.01
Valuation Ratios
The current PE Ratio of Linike Medical Group is 3.19K. Linike Medical Group’s PEG ratio is -2.00.
PE Ratio3.19K
PS Ratio0.28
PB Ratio90.03
Price to Fair Value90.03
Price to FCF-1.37K
Price to Operating Cash Flow-1.40K
PEG Ratio-2.00
Income Statement
In the last 12 months, Linike Medical Group had revenue of 8.95M and earned 991.04K in profits. Earnings per share was 0.00.
Revenue8.95M
Gross Profit8.89M
Operating Income991.04K
Pretax Income991.04K
Net Income991.04K
EBITDA1.06M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 854.22K and capital expenditures -14.84K, giving a free cash flow of 839.38K billion.
Operating Cash Flow854.22K
Free Cash Flow839.38K
Free Cash Flow per Share<0.01
Dividends & Yields
Linike Medical Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-2.12
52-Week Price Change-95.45%
50-Day Moving Average0.07
200-Day Moving Average0.46
Relative Strength Index (RSI)17.72
Average Volume (3m)13.44K
Important Dates
Linike Medical Group upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Linike Medical Group as a current ratio of 3.41, with Debt / Equity ratio of 49.17%
Current Ratio3.41
Quick Ratio2.61
Debt to Market Cap<0.01
Net Debt to EBITDA15.43
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Linike Medical Group has paid -1.00 in taxes.
Income Tax-1.00
Effective Tax Rate>-0.01
Enterprise Valuation
Linike Medical Group EV to EBITDA ratio is 3.01K, with an EV/FCF ratio of -1.37K.
EV to Sales355.19
EV to EBITDA3.01K
EV to Free Cash Flow-1.37K
EV to Operating Cash Flow-1.41K
Balance Sheet
Linike Medical Group has $1.65M in cash and marketable securities with $0.00 in debt, giving a net cash position of $15.41M billion.
Cash & Marketable Securities$1.65M
Total Debt$0.00
Net Cash$15.41M
Net Cash Per Share$0.03
Tangible Book Value Per Share$0.05
Margins
Gross margin is 98.75%, with operating margin of 11.07%, and net profit margin of 11.07%.
Gross Margin98.75%
Operating Margin11.07%
Pretax Margin11.07%
Net Profit Margin11.07%
EBITDA Margin11.80%
EBIT Margin11.07%
Analyst Forecast
The average price target for Linike Medical Group is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―